Thyrocare Technologies Ltd

Thyrocare Technologies Ltd is rated Buy by MarketsMOJO, with this rating last updated on 07 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Thyrocare Technologies Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance, reflecting a complex interplay of indicator signals. Despite a slight dip in the stock price, the company’s technical and fundamental metrics continue to suggest a positive outlook, supported by strong long-term returns and an upgraded Mojo Grade to Buy.

Thyrocare Technologies Ltd is rated Buy by MarketsMOJO, with this rating last updated on 07 May 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 26 August 2026, providing investors with the most up-to-date insight into the stock’s performance and outlook.

Thyrocare Technologies Ltd is rated Buy by MarketsMOJO, with this rating last updated on 07 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the company’s current position as of 15 August 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Thyrocare Technologies Ltd experienced a notable decline today, touching an intraday low of Rs 600.2, reflecting a price drop of 6.87% amid heightened volatility and broader market pressures.

Thyrocare Technologies Ltd, a prominent player in the Healthcare Services sector, witnessed significant trading activity on 13 Aug 2026, with a total traded value exceeding ₹239 crores. Despite this high-value turnover, the stock underperformed its sector and broader market indices, reflecting a challenging session marked by a sharp price decline and increased investor participation.

Surging to a fresh 52-week high of Rs 662 on 12 Aug 2026, Thyrocare Technologies Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 43.05% gain over the past year. This milestone caps a sustained rally driven by a confluence of bullish technical indicators and robust quarterly earnings growth.

Thyrocare Technologies Ltd, a prominent player in the healthcare services sector, reached a significant milestone on 12 August 2026 by touching an all-time high stock price of Rs.662. This achievement reflects the company’s robust financial performance and sustained market momentum, underscoring its position as a small-cap leader within its industry.

Surging to a new 52-week high of Rs 629.85 on 11 Aug 2026, Thyrocare Technologies Ltd has demonstrated remarkable price momentum, outperforming the Sensex by over 42 percentage points in the past year. This milestone caps a sustained rally supported by a confluence of bullish technical indicators and robust quarterly earnings growth.

Extending its winning streak to three sessions, Thyrocare Technologies Ltd touched a fresh all-time high of Rs 629.85 on 11 Aug 2026, outperforming the Sensex which declined 0.41% on the day. The stock’s 4.12% gain over this period reflects robust momentum supported by strong technical and fundamental factors.

With a decisive break above Rs 617.3 on 10 Aug 2026, Thyrocare Technologies Ltd has reached a fresh 52-week high, extending its impressive 39.04% annual return well beyond the broader Sensex’s modest decline of 1.60% over the same period.

Extending its winning streak to two sessions, Thyrocare Technologies Ltd surged 2.39% on 10 Aug 2026 to touch a fresh all-time high near Rs 617, outperforming the Sensex which inched up just 0.08%. This milestone caps a remarkable run where the stock has gained 39.05% over the past year, significantly outpacing the broader market.

Thyrocare Technologies Ltd is rated Buy by MarketsMOJO, with this rating last updated on 07 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 August 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and technical outlook.

The Sensex advanced 0.76% on 27 Jul 2026, yet Thyrocare Technologies Ltd outpaced the broader market with a robust 7.14% gain, touching an intraday high of Rs 612. This 7.24 percentage-point outperformance over its Healthcare Services sector peers signals a distinctly stock-specific momentum shift rather than a mere market tailwind.

Thyrocare Technologies Ltd, a prominent player in the healthcare services sector, achieved a landmark by reaching its all-time high stock price of Rs.600.50 on 27 July 2026. This milestone reflects the company’s robust financial performance and sustained market confidence, underscoring its position as a small-cap leader within its industry.

With a decisive surge to Rs 600.5 on 27 Jul 2026, Thyrocare Technologies Ltd has marked a new 52-week high, propelled by a confluence of robust technical indicators and sustained price momentum that outpaces its sector and the broader market.